Nutrien (NTR) Cash & Equivalents (2016 - 2026)

Nutrien's Cash & Equivalents history runs 11 years deep, the most recent figure standing at $777.0 million for Q1 2026.

• In Q1 2026, Cash & Equivalents fell 6.16% year-over-year to $777.0 million; the TTM figure through Mar 2026 stood at $777.0 million (down 6.16% YoY), while the FY2025 annual figure was $566.0 million, down 33.65% from the prior year.
• Cash & Equivalents was $777.0 million for Q1 2026 at Nutrien, up from $701.0 million in the prior quarter.
• In the past five years, Cash & Equivalents ranged from a high of $1.4 billion in Q2 2025 to a low of $361.0 million in Q1 2023.
• Historically, Cash & Equivalents has averaged $746.5 million across 5 years, with a median of $737.0 million in 2023.
• The sharpest annual moves came in 2022 and 2025: Cash & Equivalents tumbled 60.37% in 2022, then soared 96.21% in 2025.
• A 5-year view of Cash & Equivalents shows it stood at $901.0 million in 2022, then gained by 4.44% to $941.0 million in 2023, then dropped by 9.35% to $853.0 million in 2024, then declined by 17.82% to $701.0 million in 2025, then climbed by 10.84% to $777.0 million in 2026.
• The last three Cash & Equivalents figures came in at $777.0 million (Q1 2026), $701.0 million (Q4 2025), and $624.0 million (Q3 2025), per Business Quant data.